Walgreens: Here’s What Comes Next

Summary

  • WBA stock drops 57% YTD, hitting 27-year lows, amid disappointing Q3 results and profit outlook cuts.
  • Challenging environment with weak consumer spending and inflation pressures are impacting Walgreens’ performance.
  • Despite facing cash flow crisis and restructuring, WBA posts 2.6% sales growth driven by robust healthcare segment performance.
  • Potential for rebound with aggressive cost-cutting and strategic shift to healthcare.
  • By year-end, stock price targets range from $8.25 to $23.35, supported by volume price trends and RSI indicators.

Investment Thesis

Walgreens Boots Alliance (NASDAQ:WBA) stock has imploded to 27-year lows after going down by more than 57% year to date. The sell-off has gathered momentum after the drugstore delivered disappointing fiscal third-quarter results

READ FULL ARTICLE HERE!